INSULET CORP (PODD) Stock Price, Forecast & Analysis
USA - NASDAQ:PODD - US45784P1012 - Common Stock
PODD Key Statistics, Chart & Performance
The current stock price of PODD is 336.84 USD. In the past month the price increased by 7.81%. In the past year, price increased by 29.49%.
PODD Latest News, Press Relases and Analysis
PODD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.82 | 224.21B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.49 | 205.21B | ||
| BSX | BOSTON SCIENTIFIC CORP | 35.3 | 154.29B | ||
| SYK | STRYKER CORP | 27.89 | 140.44B | ||
| IDXX | IDEXX LABORATORIES INC | 56.59 | 57.08B | ||
| BDX | BECTON DICKINSON AND CO | 13.32 | 55.07B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.3 | 50.24B | ||
| RMD | RESMED INC | 25.54 | 36.90B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.34 | 34.23B | ||
| DXCM | DEXCOM INC | 32.05 | 23.38B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.13 | 17.83B | ||
| HOLX | HOLOGIC INC | 17.46 | 16.58B |
Related stock screener links
About PODD
Company Profile
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts and currently employs 3,900 full-time employees. The company went IPO on 2007-05-15. The company is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. The company also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.
Company Info
INSULET CORP
100 Nagog Park
Acton MASSACHUSETTS 01720 US
CEO: Shacey Petrovic
Employees: 3900
Phone: 19786007000
INSULET CORP / PODD FAQ
Can you describe the business of INSULET CORP?
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts and currently employs 3,900 full-time employees. The company went IPO on 2007-05-15. The company is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. The company also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.
What is the stock price of INSULET CORP today?
The current stock price of PODD is 336.84 USD. The price increased by 3.24% in the last trading session.
What is the dividend status of INSULET CORP?
PODD does not pay a dividend.
How is the ChartMill rating for INSULET CORP?
PODD has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
On which exchange is PODD stock listed?
PODD stock is listed on the Nasdaq exchange.
How is the valuation of INSULET CORP (PODD) based on its PE ratio?
The PE ratio for INSULET CORP (PODD) is 73.71. This is based on the reported non-GAAP earnings per share of 4.57 and the current share price of 336.84 USD.
What is the market capitalization of PODD stock?
INSULET CORP (PODD) has a market capitalization of 23.71B USD. This makes PODD a Large Cap stock.
PODD Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to PODD. When comparing the yearly performance of all stocks, PODD is one of the better performing stocks in the market, outperforming 79.75% of all stocks.
PODD Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to PODD. PODD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
PODD Financial Highlights
Over the last trailing twelve months PODD reported a non-GAAP Earnings per Share(EPS) of 4.57. The EPS increased by 27.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.76% | ||
| ROA | 8.13% | ||
| ROE | 17.79% | ||
| Debt/Equity | 0.68 |
PODD Forecast & Estimates
33 analysts have analysed PODD and the average price target is 367.77 USD. This implies a price increase of 9.18% is expected in the next year compared to the current price of 336.84.
For the next year, analysts expect an EPS growth of 42.69% and a revenue growth 27.75% for PODD